Biocon Biologics completes integration of Viatris Biosimilars’ Business in North America EP News Bureau Sep 6, 2023 With the completion of the North America integration, the existing commercialised portfolio of biosimilars, Ogiviri…
Biocon Biologics launches Hulio biosimilar in US EP News Bureau Jul 4, 2023 HULIO is available at a list price (wholesale acquisition cost) of five per cent below the current Humira list price.…
